𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The psychosocial impact of human papillomavirus testing in primary cervical screening—a study within a randomized trial

✍ Scribed by H.C. KITCHENER; I. FLETCHER; C. ROBERTS; P. WHEELER; M. ALMONTE; P. MAGUIRE


Book ID
109086316
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
77 KB
Volume
18
Category
Article
ISSN
1048-891X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Accuracy of human papillomavirus testing
✍ Rengaswamy Sankaranarayanan; Ramdas Chatterji; Surendra S. Shastri; Ramani S. We 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 132 KB 👁 1 views

## Abstract The knowledge that cervical neoplasia are caused by human papillomavirus (HPV) infection has led to the evaluation of its role in screening. We evaluated the accuracy of HPV testing by Hybrid capture II (HC II) method in detecting cervical intraepithelial neoplasia grade 2 and 3 (CIN 2

Randomized controlled trial of human pap
✍ Marie-Hélène Mayrand; Eliane Duarte-Franco; François Coutlée; Isabel Rodrigues; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 403 KB 👁 1 views

## Abstract Since infection with oncogenic human papillomavirus (HPV) has been considered a necessary cause of cervical cancer, tests for oncogenic HPV types have been proposed as adjuncts or replacements to Pap cytology. We designed the Canadian Cervical Cancer Screening Trial (CCCaST) to compare

A report on the current status of Europe
✍ Philip Davies; Marc Arbyn; Joakim Dillner; Henry C. Kitchener; Chris J.L.M. Meij 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 87 KB 👁 1 views

## Abstract Cervical cancer remains a significant public health concern, both at a global and a European level. A number of new technologies such as diagnostic tests for human papillomavirus (HPV) have a potential to assist with the reduction of this disease. However, both the efficacy and the cost

Evaluation of oncogenic human papillomav
✍ Joseph Monsonego; Michael G. Hudgens; Laurent Zerat; Jean-Claude Zerat; Kari Syr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 335 KB 👁 2 views

The APTIMA V R HPV Assay (AHPV) allows detection of 14 high-risk human papillomavirus (HPV) RNA types in cervical specimens. Until present, the assay has been compared to HPV DNA tests only in triage settings. Herein, we compare AHPV with a DNA assay (Hybrid Capture V R 2; HC2) and liquid-based cyto